查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947913

肠道疾病检测市场分析及预测（至2035年）：依类型、产品、服务、技术、应用、最终使用者、流程、功能及安装类型划分

Enteric Disease Testing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Process, Functionality, Installation Type
出版日期: | 出版商: Global Insight Services | 英文 344 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计肠道疾病检测市场规模将从2024年的36亿美元成长到2034年的56亿美元，复合年增长率约为2.7%。该市场涵盖用于检测引起疾病的消化器官系统病原体（例如沙门氏菌、大肠桿菌和诺罗病毒）的诊断工具和技术。市场包括快速检测、分子诊断和基于培养的方法。食源性疾病发生率的上升和卫生意识的增强是推动市场成长的主要因素。监管标准和对高效疾病控制的需求正在推动技术创新，旨在提高全球医疗机构和实验室的检测准确性、速度和易用性。

由于诊断技术的进步和人们对肠道感染疾病的认识不断提高，肠道疾病检测市场正经历强劲成长。分子诊断领域凭藉其高准确性和快速出结果的优势，展现出最高的成长率。基于PCR的检测和次世代定序是提升检测能力的关键技术。免疫检测是成长第二快的领域，由于其成本效益高且易于使用，已被广泛应用于临床。 PCR检测凭藉其高准确性在分子诊断领域占据主导地位。同时，快速免疫检测在免疫检测领域也占据主导地位。在各种情况下对快速准确结果的需求推动了就地检验的需求。自动化检测解决方案因其能够简化工作流程并减少人为错误而备受关注。研发投入的不断增加正在推动创新，带来新的生物标记和先进的检测方法。这些趋势凸显了市场的活力和盈利的潜在商机。

市场区隔
按类型 细菌、病毒和寄生虫检测
产品 试剂/试剂盒、设备、软体
服务 检查服务、诊断服务
科技 分子诊断、免疫检测、传统培养方法、快速检测
目的 临床诊断、环境检测、食品安全
最终用户 医院和诊所、诊断检查室实验室、食品和饮料行业
流程 检体采集、样本製备、检测与分析
功能 全自动、半自动、手动
安装类型 桌面式和可携式

肠道疾病检测市场正经历强劲成长，这主要得益于创新产品的推出和动态定价策略的推动。主要企业正透过在其产品组合中添加先进的诊断技术来拓展业务，这些技术承诺提供快速且准确的检测结果。这种策略扩张辅以旨在获取更大市场份额的竞争性定价模式。策略联盟和併购进一步影响市场的竞争格局，从而创造了一个有利于创新和市场渗透的环境。肠道疾病检测市场的竞争异常激烈，主要企业正透过技术创新和策略联盟争夺主导。法规结构，尤其是在北美和欧洲，对于塑造市场动态和确保符合严格的品质标准至关重要。这些法规促进了创新，提高了产品功效，并增强了消费者信心。儘管市场高度分散，但新兴市场和技术整合仍蕴藏着巨大的成长机会。随着不断变化的法规和竞争策略塑造市场的未来发展轨迹，市场环境仍然充满活力。

主要趋势和驱动因素：

由于全球胃肠道感染疾病率不断上升，肠道疾病检测市场正经历强劲成长。人们对食品安全和卫生意识的提高推动了对先进诊断解决方案的需求。关键趋势包括分子诊断技术的应用，该技术能够快速且准确地检测病原体。人工智慧与诊断工具的融合提高了检测的准确性和效率。此外，就地检验的普及正在改变市场格局，实现及时诊断和治疗。受消费者对便利性和隐私性的偏好驱动，家用检测套组的普及势头强劲。政府遏制感染疾病的倡议进一步推动了市场成长。此外，对个人化医疗的日益重视也推动了客製化检测解决方案的开发。新兴市场医疗基础设施的不断完善蕴藏着许多机会。投资于创新技术和策略合作的公司将能够更好地掌握这些趋势，确保市场可持续成长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 细菌学检测
    • 病毒检测
    • 寄生虫检测
  • 市场规模及预测：依产品划分
    • 试剂和试剂盒
    • 装置
    • 软体
  • 市场规模及预测：依服务划分
    • 体检服务
    • 诊断服务
  • 市场规模及预测：依技术划分
    • 分子诊断
    • 免疫检测
    • 传统培养方法
    • 快速检测
  • 市场规模及预测：依应用领域划分
    • 临床诊断
    • 环境检查
    • 食品安全
  • 市场规模及预测：依最终用户划分
    • 医院和诊所
    • 诊断检查室
    • 研究所
    • 食品饮料业
  • 市场规模及预测：依製程划分
    • 检体采集
    • 样品製备
    • 侦测
    • 分析
  • 市场规模及预测：依功能划分
    • 自动的
    • 半自动
    • 手动的
  • 市场规模及预测：依安装类型划分
    • 桌面型
    • 携带式的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Bio-Rad Laboratories
  • Dia Sorin
  • Quidel Ortho Corporation
  • Meridian Bioscience
  • Luminex Corporation
  • Gen Mark Diagnostics
  • Alere
  • Ora Sure Technologies
  • Chembio Diagnostic Systems
  • Trinity Biotech
  • Sekisui Diagnostics
  • EKF Diagnostics
  • Thermo Fisher Scientific
  • T2 Biosystems
  • Becton Dickinson
  • Cepheid
  • Roche Diagnostics
  • bio Merieux
  • Hologic
  • Abbott Laboratories

第九章：关于我们

简介目录
Product Code: GIS21027

Enteric Disease Testing Market is anticipated to expand from $3.6 billion in 2024 to $5.6 billion by 2034, growing at a CAGR of approximately 2.7%. The Enteric Disease Testing Market encompasses diagnostic tools and technologies designed to detect gastrointestinal pathogens causing diseases such as salmonella, E. coli, and norovirus. This market includes rapid tests, molecular diagnostics, and culture-based methods. Rising incidence of foodborne illnesses and increasing awareness about hygiene propel market growth. Innovations focus on enhancing accuracy, speed, and ease of use, catering to healthcare facilities and laboratories worldwide, driven by regulatory standards and the need for efficient disease management.

The Enteric Disease Testing Market is experiencing robust growth, propelled by advancements in diagnostic technologies and increasing awareness of enteric diseases. The molecular diagnostics segment is the top performer, driven by its high accuracy and rapid results. PCR-based tests and next-generation sequencing are pivotal, enhancing detection capabilities. Immunoassays follow closely, reflecting their widespread use in clinical settings for their cost-effectiveness and ease of use. Within molecular diagnostics, PCR tests dominate due to their precision, while rapid immunoassays lead in the immunoassay category. The demand for point-of-care testing is rising, driven by the need for quick and accurate results in diverse settings. Automated testing solutions are gaining traction, improving workflow efficiency and reducing human error. Increased investment in research and development is fostering innovation, with novel biomarkers and advanced detection methods on the horizon. These trends underscore the market's dynamic nature and potential for lucrative opportunities.

Market Segmentation
TypeBacterial Testing, Viral Testing, Parasitic Testing
ProductReagents and Kits, Instruments, Software
ServicesConsulting Services, Diagnostic Services
TechnologyMolecular Diagnostics, Immunoassays, Traditional Cultures, Rapid Tests
ApplicationClinical Diagnostics, Environmental Testing, Food Safety
End UserHospitals and Clinics, Diagnostic Laboratories, Research Institutes, Food and Beverage Industry
ProcessSample Collection, Sample Preparation, Detection, Analysis
FunctionalityAutomated, Semi-Automated, Manual
Installation TypeBench-top, Portable

The Enteric Disease Testing Market is witnessing robust growth, propelled by innovative product launches and dynamic pricing strategies. Leading companies are expanding their portfolios to include advanced diagnostic technologies that promise rapid and accurate results. This strategic expansion is complemented by competitive pricing models designed to capture a larger market share. The market's competitive landscape is further influenced by strategic alliances and mergers, fostering a climate of innovation and market penetration. Competition in the Enteric Disease Testing Market is intense, with key players vying for dominance through technological advancements and strategic partnerships. Regulatory frameworks, particularly in North America and Europe, are pivotal in shaping market dynamics and ensuring compliance with stringent quality standards. These regulations drive innovation and enhance product efficacy, fostering consumer trust. The market is characterized by a high degree of fragmentation, yet opportunities abound for growth through emerging markets and technological integration. The landscape remains dynamic, with evolving regulations and competitive strategies shaping future trajectories.

Geographical Overview:

The enteric disease testing market is experiencing notable growth across various regions, each exhibiting unique characteristics. North America leads the market, driven by advanced healthcare infrastructure and increased awareness of enteric diseases. The prevalence of gastrointestinal infections in the region further accelerates demand for effective testing solutions. Europe follows as a significant player, with strong emphasis on public health initiatives and stringent regulatory frameworks. This ensures high standards in diagnostic testing and fosters market expansion. Asia Pacific is witnessing rapid growth, propelled by rising healthcare investments and increasing incidence of enteric diseases. The region's improving healthcare access further boosts market potential. Latin America and the Middle East & Africa are emerging markets with promising prospects. In Latin America, growing healthcare expenditure and awareness campaigns are enhancing market growth. Meanwhile, the Middle East & Africa are recognizing the importance of enteric disease testing in improving public health outcomes, paving the way for future opportunities.

The enteric disease testing market is navigating a complex landscape of global tariffs, geopolitical risks, and evolving supply chain dynamics. In Japan and South Korea, heightened trade tensions prompt a strategic pivot towards enhancing domestic production capacities and reducing dependency on imports. China is accelerating its investment in biotechnological self-reliance to mitigate the impact of foreign tariffs and sanctions. Taiwan, while maintaining its critical role in the technology supply chain, faces geopolitical vulnerabilities that necessitate strategic alliances and diversification. Globally, the parent market is robust, driven by increasing demand for rapid diagnostics and public health initiatives. By 2035, the market is expected to evolve with advancements in molecular diagnostics and AI integration. Middle East conflicts may indirectly affect global supply chains through energy price volatility, influencing production costs and logistics.

Key Trends and Drivers:

The enteric disease testing market is experiencing robust growth, driven by rising incidences of gastrointestinal infections globally. Increasing awareness about food safety and hygiene is propelling demand for advanced diagnostic solutions. Key trends include the adoption of molecular diagnostic techniques, offering rapid and accurate pathogen detection. The integration of artificial intelligence in diagnostic tools is enhancing test precision and efficiency. Moreover, the expansion of point-of-care testing is transforming the market landscape, enabling timely diagnosis and treatment. The shift towards home-based testing kits is gaining traction, fueled by consumer preference for convenience and privacy. Government initiatives to curb infectious diseases are further stimulating market growth. Additionally, the growing focus on personalized medicine is fostering the development of tailored testing solutions. Opportunities abound in emerging markets, where healthcare infrastructure is expanding. Companies investing in innovative technologies and strategic partnerships are well-positioned to capitalize on these trends, ensuring sustained market momentum.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Installation Type

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Bacterial Testing
    • 4.1.2 Viral Testing
    • 4.1.3 Parasitic Testing
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents and Kits
    • 4.2.2 Instruments
    • 4.2.3 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting Services
    • 4.3.2 Diagnostic Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Molecular Diagnostics
    • 4.4.2 Immunoassays
    • 4.4.3 Traditional Cultures
    • 4.4.4 Rapid Tests
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Diagnostics
    • 4.5.2 Environmental Testing
    • 4.5.3 Food Safety
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals and Clinics
    • 4.6.2 Diagnostic Laboratories
    • 4.6.3 Research Institutes
    • 4.6.4 Food and Beverage Industry
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Sample Collection
    • 4.7.2 Sample Preparation
    • 4.7.3 Detection
    • 4.7.4 Analysis
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Automated
    • 4.8.2 Semi-Automated
    • 4.8.3 Manual
  • 4.9 Market Size & Forecast by Installation Type (2020-2035)
    • 4.9.1 Bench-top
    • 4.9.2 Portable

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Functionality
      • 5.2.1.9 Installation Type
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Functionality
      • 5.2.2.9 Installation Type
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Functionality
      • 5.2.3.9 Installation Type
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Functionality
      • 5.3.1.9 Installation Type
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Functionality
      • 5.3.2.9 Installation Type
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Functionality
      • 5.3.3.9 Installation Type
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Functionality
      • 5.4.1.9 Installation Type
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Functionality
      • 5.4.2.9 Installation Type
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Functionality
      • 5.4.3.9 Installation Type
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Functionality
      • 5.4.4.9 Installation Type
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Functionality
      • 5.4.5.9 Installation Type
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Functionality
      • 5.4.6.9 Installation Type
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Functionality
      • 5.4.7.9 Installation Type
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Functionality
      • 5.5.1.9 Installation Type
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Functionality
      • 5.5.2.9 Installation Type
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Functionality
      • 5.5.3.9 Installation Type
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Functionality
      • 5.5.4.9 Installation Type
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Functionality
      • 5.5.5.9 Installation Type
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Functionality
      • 5.5.6.9 Installation Type
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Functionality
      • 5.6.1.9 Installation Type
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Functionality
      • 5.6.2.9 Installation Type
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Functionality
      • 5.6.3.9 Installation Type
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Functionality
      • 5.6.4.9 Installation Type
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Functionality
      • 5.6.5.9 Installation Type

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bio- Rad Laboratories
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Dia Sorin
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Quidel Ortho Corporation
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Meridian Bioscience
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Luminex Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Gen Mark Diagnostics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Alere
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ora Sure Technologies
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Chembio Diagnostic Systems
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Trinity Biotech
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Sekisui Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 EKF Diagnostics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Thermo Fisher Scientific
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 T2 Biosystems
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Becton Dickinson
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Cepheid
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Roche Diagnostics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 bio Merieux
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hologic
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Abbott Laboratories
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us